FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Ketorolac Trom 30 mg/mL Injection Recall

Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Oct 4, 2017
Recall ID
D-1176-2017
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Ketorolac Trom 30 mg/mL Injection starting Aug 22, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1176-2017 on Oct 4, 2017. Reason: Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt. Status: Terminated.

Why it was recalled

Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.

Product description

Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.

Lot numbers, UPCs & expiration codes

Lot #: a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017

Where it was sold

Product was distributed to one consignee in Louisiana.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1176-2017
Classification
Class II
Status
Terminated
Recall initiated
Aug 22, 2017
FDA report date
Oct 4, 2017
Quantity
40 vials
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-1176-2017, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
78146
Address
625 Kolter Dr Ste 4
Code information
Lot #: a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017
Postal code
15701-3571
Report date
Oct 4, 2017
Product type
Drugs
Recall number
D-1176-2017
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
40 vials
Termination date
Jan 3, 2018
Reason for recall
Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.
Distribution pattern
Product was distributed to one consignee in Louisiana.
Recall initiation date
Aug 22, 2017
Initial firm notification
Letter
Center classification date
Sep 22, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1176-2017, published Oct 4, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls